Acticor Biotech SAS
EPA:ALACT.PA
0.34 (EUR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2018 Q2 | 2017 Q2 | 2016 Q2 | 2015 Q2 | 2014 Q2 | 2013 Q2 | 2012 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.721 | 0 | 0.007 | 0 | 0.05 | 0 | 0.036 | 0 | 0.049 | 0 | 0.051 | 0 | 0.059 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.721 | 0 | -0.007 | 0 | -0.05 | 0 | -0.036 | 0 | -0.049 | 0 | -0.051 | 0 | -0.059 | 0 | -0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 2.136 | 0.004 | 12.106 | 3.537 | 6.895 | 3.448 | 6.237 | 0.003 | 5.107 | 0.003 | 5.663 | 0.003 | 3.892 | 0.002 | 3.353 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0.001 | 0.001 | 0.001 | 0.908 | 0.001 | 0.795 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 2.018 | 0 | 2.86 | 0.539 | 2.256 | 0.343 | 2.303 | 0 | 2.721 | 0 | 1.301 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 2.019 | 0.001 | 2.861 | 1.446 | 2.257 | 1.138 | 2.304 | 0.001 | 2.722 | 0.001 | 1.302 | 0.001 | 0.84 | 0 | 0.867 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| -0.04 | 0 | -0.025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 4.195 | 0.005 | 14.992 | 4.272 | 9.152 | 4.127 | 8.541 | 0.004 | 7.829 | 0.003 | 6.965 | 0.003 | 4.732 | 0.002 | 4.22 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income
| -4.916 | -0.004 | -14.999 | -4.411 | -9.202 | -3.926 | -8.577 | -0.004 | -7.878 | -0.003 | -7.016 | -0.003 | -4.791 | -0.002 | -4.26 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 0.181 | 0 | -1 | -0.63 | -0.481 | -0.359 | 0.244 | -0 | 0.02 | -0 | 0.33 | -0 | -0.047 | -0 | 0.057 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Before Tax
| -4.735 | -0.004 | -15.999 | -5.041 | -9.683 | -4.284 | -8.333 | -0.004 | -7.858 | -0.003 | -6.686 | -0.003 | -4.838 | -0.002 | -4.203 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 3.824 | 0 | -5.918 | -0.038 | -1.115 | -0.019 | -1.023 | 0 | -1.156 | 0 | -0.78 | 0 | -0.61 | 0 | -0.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income
| -8.559 | -0.004 | -10.081 | -5.041 | -8.568 | -4.284 | -7.31 | -0.004 | -6.702 | -0.003 | -5.906 | -0.003 | -4.228 | -0.002 | -3.423 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.68 | -0 | -0.87 | -0.44 | -0.81 | -0.41 | -0.69 | -0 | -0.64 | -0 | -0.56 | -0 | -0.4 | -0 | -0.32 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS Diluted
| -0.68 | -0 | -0.87 | -0.43 | -0.81 | -0.41 | -0.69 | -0 | -0.64 | -0 | -0.56 | -0.38 | -0.4 | -0 | -0.32 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA
| -4.195 | -0.004 | -14.992 | -4.407 | -9.152 | -3.917 | -8.541 | -0.004 | -7.829 | -0.003 | -6.965 | -0.003 | -4.732 | -0.002 | -4.22 | -0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |